Genmab — Maj 2019

[E_L]

Enapotamab Vedotin (HuMax-AXL-ADC) trial enlarged from 292 to 374 patients (extra cohorts being added i assume, as expected) https://clinicaltrials.gov/ct2/history/NCT02988817?A=12&B=13&C=merged#StudyPageTop

[troldmanden]

Was this expected? Thats about 80 DKK more to run this ekstra cohort

[troldmanden]

80 mill DKK

[E_L]

Third Quarter Update
• September: Based on encouraging signs of early activity, one of the lung cancer cohorts in the
ongoing Phase I/II study of enapotamab vedotin will be expanded. In addition, cohorts in mixed
solid tumors and ovarian cancer are being added to the study.

[forsent]

er der egentlig ikke kommet salgstal endnu for april??

[hda]

USD 144

[hda]

Det er recepttal, ikke salgstal

[polle1]

Du kom for sent, forsent

[Plimsoller]

God morgen

[Helge_LarsenPI-redaktør]

God morgen.

[Parasitism]

God morgen

[polle1]

God morgen og god dag

[Helge_LarsenPI-redaktør]

Er Nordnet nede?

[Helge_LarsenPI-redaktør]

Sorry..Det er min lånte labtop som driller.

[polle1]

Håber der snart kommer noget godt nyt, så vi kan få sparket 1200 til hjørne for good !!

[E_L]

This weekend we "celebrate" the 1-year anniversary of the famous Dara Anti-PD-(L)1 announcement

[E_L]

Friday May 25, we closed at 1192.5, on Monday we hit a low of 880.
Funny that it is exactly a year later that we breach 1200 again.

[Helge_LarsenPI-redaktør]

A tuff year for many Genmab-investors.

[Sukkeralf]

Maybe also a learning about analyst - solid tumors that the analyst valuated to 0......and now a year later we finaly recovered the 20% fall !

[Helge_LarsenPI-redaktør]

Spot on Sugar.